Establishment and maintenance of thyroid organoids from human cancer cells.

STAR Protoc

Department of Translational and Precision Medicine, Sapienza University of Rome, Viale del Policlinico 155, 00161 Roma, Italy.

Published: June 2022

AI Article Synopsis

  • A protocol is outlined for creating organoids from human thyroid cancer cells using patient-derived cells.
  • Both organoids and primary cell lines are established, with the organoid medium enhanced by conditioned medium from the primary line.
  • This approach allows organoids to be cultured for up to 10 months while preserving their original genetic and phenotypic traits.

Article Abstract

Here, we describe a protocol to generate organoids from human thyroid cancer cells. Starting from the same patient-derived cells, we establish both organoids and primary lines. The organoid medium is supplemented with conditioned medium obtained from the primary cell line. This modification enables culture of the organoid lines for up to 10 months. Even after long-term culture, the organoids retain the genetic and phenotypic characteristics of their tissue of origin.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115321PMC
http://dx.doi.org/10.1016/j.xpro.2022.101393DOI Listing

Publication Analysis

Top Keywords

organoids human
8
establishment maintenance
4
maintenance thyroid
4
organoids
4
thyroid organoids
4
human cancer
4
cancer cells
4
cells describe
4
describe protocol
4
protocol generate
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!